Daily Probiotic's (Lactobacillus Casei Shirota) Reduction Of Infection Incidence In Athletes

Effect Decrease
Values Risk of URTI symptoms lasting a week or longer was 36% lower in treatment group compared to placebo.
Trial Design Randomized trial
Trial Length 1-6 months
Number of Subjects 84
Sex Both Genders
Age Range 18-29, 30-44, 45-64
Body Types Trained
Notes for this study:
84 endurance athletes were supplemented with _L. casei_ shirota (6.5 x 10^9^ CFU daily for 16 weeks) while training during the winter months. Most immunological parameters did not change except for salivary IgA levels, which increased after 8 weeks of supplementation.

The supplemented athletes experienced a decreased risk of upper respiratory tract infection (URTI) symptoms. However, the severity and duration of symptoms, if displayed, did not differ as compared to placebo.
Funding issues for this study:
Funded by Yakult Honsha, a manufacturer of probiotic milk.

Full details on all 2 studies are available to Examine Members. Try out the Examine Membership with a 14-day free trial.

Already a Member? Log in now to access.